Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 15618 | 26.77 |
09:34 ET | 2320 | 26.82 |
09:36 ET | 1966 | 26.83 |
09:38 ET | 3784 | 26.8 |
09:39 ET | 2115 | 26.755 |
09:41 ET | 3488 | 26.78 |
09:43 ET | 3611 | 26.81 |
09:45 ET | 1323 | 26.81 |
09:48 ET | 2850 | 26.775 |
09:50 ET | 4130 | 26.81 |
09:52 ET | 3545 | 26.93 |
09:54 ET | 1400 | 26.93 |
09:56 ET | 2236 | 26.96 |
09:57 ET | 4675 | 26.92 |
09:59 ET | 6237 | 26.95 |
10:01 ET | 4190 | 26.93 |
10:03 ET | 4177 | 26.975 |
10:06 ET | 7199 | 26.96 |
10:08 ET | 2200 | 26.96 |
10:10 ET | 7400 | 26.97 |
10:12 ET | 4964 | 26.94 |
10:14 ET | 4521 | 26.89 |
10:15 ET | 7244 | 26.94 |
10:17 ET | 3400 | 26.96 |
10:19 ET | 4800 | 26.99 |
10:21 ET | 2296 | 26.97 |
10:24 ET | 4615 | 27 |
10:26 ET | 8124 | 26.995 |
10:28 ET | 41891 | 26.97 |
10:30 ET | 5573 | 26.955 |
10:32 ET | 10727 | 26.985 |
10:33 ET | 4429 | 26.975 |
10:35 ET | 3652 | 26.97 |
10:37 ET | 2330 | 26.945 |
10:39 ET | 2500 | 26.98 |
10:42 ET | 4363 | 26.975 |
10:44 ET | 835 | 26.965 |
10:46 ET | 4855 | 26.98 |
10:48 ET | 2118 | 26.985 |
10:50 ET | 3456 | 26.985 |
10:51 ET | 12284 | 26.978 |
10:53 ET | 4437 | 26.985 |
10:55 ET | 3361 | 26.98 |
10:57 ET | 5384 | 26.955 |
11:00 ET | 2300 | 26.985 |
11:02 ET | 4600 | 26.99 |
11:04 ET | 2176 | 26.985 |
11:06 ET | 1900 | 26.98 |
11:08 ET | 4875 | 26.9891 |
11:09 ET | 18942 | 27 |
11:11 ET | 3600 | 26.97 |
11:13 ET | 1671 | 26.965 |
11:15 ET | 5009 | 26.98 |
11:18 ET | 6514 | 26.98 |
11:20 ET | 1375 | 26.9701 |
11:22 ET | 2526 | 26.99 |
11:24 ET | 3705 | 26.975 |
11:26 ET | 606 | 26.98 |
11:27 ET | 2102 | 26.975 |
11:29 ET | 48021 | 26.945 |
11:31 ET | 8431 | 26.885 |
11:33 ET | 18397 | 26.915 |
11:36 ET | 67611 | 26.935 |
11:38 ET | 3167 | 26.93 |
11:40 ET | 7386 | 26.935 |
11:42 ET | 1779 | 26.935 |
11:44 ET | 2227 | 26.935 |
11:45 ET | 4200 | 26.96 |
11:47 ET | 6787 | 26.965 |
11:49 ET | 4805 | 26.98 |
11:51 ET | 2825 | 26.965 |
11:54 ET | 3175 | 26.97 |
11:56 ET | 12796 | 26.975 |
11:58 ET | 6096 | 26.98 |
12:00 ET | 1700 | 26.985 |
12:02 ET | 26708 | 26.9706 |
12:03 ET | 7520 | 26.965 |
12:05 ET | 43398 | 26.975 |
12:07 ET | 11375 | 27.01 |
12:09 ET | 4607 | 27.04 |
12:12 ET | 4535 | 27 |
12:14 ET | 1957 | 26.99 |
12:16 ET | 4475 | 26.98 |
12:18 ET | 134 | 26.98 |
12:20 ET | 2667 | 26.98 |
12:21 ET | 400 | 26.985 |
12:23 ET | 736 | 26.98 |
12:25 ET | 7973 | 26.99 |
12:27 ET | 5249 | 26.98 |
12:30 ET | 468 | 26.975 |
12:32 ET | 3160 | 26.965 |
12:34 ET | 7246 | 26.975 |
12:36 ET | 8755 | 26.975 |
12:38 ET | 2810 | 26.98 |
12:39 ET | 3996 | 26.9801 |
12:41 ET | 4765 | 26.9725 |
12:43 ET | 741 | 26.975 |
12:45 ET | 743 | 26.97 |
12:48 ET | 9540 | 26.99 |
12:50 ET | 5667 | 26.99 |
12:52 ET | 8833 | 26.99 |
12:54 ET | 4857 | 26.985 |
12:56 ET | 2280 | 26.99 |
12:57 ET | 7380 | 26.99 |
12:59 ET | 4355 | 26.98 |
01:01 ET | 7293 | 26.975 |
01:03 ET | 2869 | 26.96 |
01:06 ET | 6118 | 26.955 |
01:08 ET | 6010 | 26.94 |
01:10 ET | 5202 | 26.945 |
01:12 ET | 1300 | 26.945 |
01:14 ET | 5136 | 26.95 |
01:15 ET | 4038 | 26.925 |
01:17 ET | 3065 | 26.925 |
01:19 ET | 8191 | 26.905 |
01:21 ET | 1523 | 26.905 |
01:24 ET | 8054 | 26.93 |
01:26 ET | 5000 | 26.93 |
01:28 ET | 4127 | 26.95 |
01:30 ET | 1199 | 26.95 |
01:32 ET | 42086 | 26.87 |
01:33 ET | 8239 | 26.88 |
01:35 ET | 1200 | 26.885 |
01:37 ET | 4620 | 26.885 |
01:39 ET | 5616 | 26.89 |
01:42 ET | 18596 | 26.885 |
01:44 ET | 1627 | 26.89 |
01:46 ET | 34545 | 26.905 |
01:48 ET | 35493 | 26.885 |
01:50 ET | 8175 | 26.85 |
01:51 ET | 6450 | 26.8 |
01:53 ET | 2415 | 26.74 |
01:55 ET | 8732 | 26.78 |
01:57 ET | 4901 | 26.74 |
02:00 ET | 3881 | 26.75 |
02:02 ET | 4154 | 26.785 |
02:04 ET | 3366 | 26.78 |
02:06 ET | 1200 | 26.785 |
02:08 ET | 4098 | 26.78 |
02:09 ET | 4185 | 26.76 |
02:11 ET | 3427 | 26.765 |
02:13 ET | 3321 | 26.73 |
02:15 ET | 6635 | 26.75 |
02:18 ET | 2200 | 26.75 |
02:20 ET | 6418 | 26.745 |
02:22 ET | 9493 | 26.75 |
02:24 ET | 2192 | 26.745 |
02:26 ET | 2202 | 26.745 |
02:27 ET | 7178 | 26.735 |
02:29 ET | 5714 | 26.725 |
02:31 ET | 2070 | 26.73 |
02:33 ET | 4183 | 26.75 |
02:36 ET | 7295 | 26.72 |
02:38 ET | 1623 | 26.71 |
02:40 ET | 1400 | 26.715 |
02:42 ET | 5636 | 26.73 |
02:44 ET | 4693 | 26.725 |
02:45 ET | 5458 | 26.72 |
02:47 ET | 1518 | 26.725 |
02:49 ET | 4200 | 26.74 |
02:51 ET | 7545 | 26.745 |
02:54 ET | 2517 | 26.745 |
02:56 ET | 7785 | 26.745 |
02:58 ET | 4796 | 26.745 |
03:00 ET | 3692 | 26.7405 |
03:02 ET | 5532 | 26.735 |
03:03 ET | 7117 | 26.71 |
03:05 ET | 7577 | 26.71 |
03:07 ET | 4619 | 26.735 |
03:09 ET | 5958 | 26.7 |
03:12 ET | 5603 | 26.6856 |
03:14 ET | 1751 | 26.665 |
03:16 ET | 5565 | 26.66 |
03:18 ET | 9692 | 26.65 |
03:20 ET | 3705 | 26.64 |
03:21 ET | 9511 | 26.64 |
03:23 ET | 2818 | 26.64 |
03:25 ET | 6703 | 26.65 |
03:27 ET | 5542 | 26.65 |
03:30 ET | 1719 | 26.64 |
03:32 ET | 7819 | 26.64 |
03:34 ET | 3636 | 26.625 |
03:36 ET | 7719 | 26.615 |
03:38 ET | 8089 | 26.62 |
03:39 ET | 8642 | 26.665 |
03:41 ET | 7618 | 26.68 |
03:43 ET | 8934 | 26.635 |
03:45 ET | 8188 | 26.655 |
03:48 ET | 6772 | 26.66 |
03:50 ET | 7105 | 26.67 |
03:52 ET | 11195 | 26.685 |
03:54 ET | 16753 | 26.68 |
03:56 ET | 68515 | 26.64 |
03:57 ET | 44520 | 26.6 |
03:59 ET | 86768 | 26.58 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.1B | 14.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.5x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 22.1x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.5x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.1B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.16% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.9x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.